x
Breaking News
More () »

Charlotte's Leading Local News: Weather, Traffic, Sports and more | Charlotte, North Carolina | WCNC.com

Biogen to offer potentially life-saving ALS drug to patients this year

Patients fighting rare and fatal diseases hang their hope on new experimental drugs not yet approved, but sometimes, they are denied access.

CHARLOTTE, N.C. — Drugmaker Biogen announced it will offer the drug Tofersen to ALS patients in certain circumstances this summer. 

Earlier this year, WCNC Charlotte's Bill McGinty began following the story of Lisa Stockman Mauriello, a woman dying from ALS, who pleaded with Biogen for access to Tofersen under "compassionate use."

After initially rejecting her plea, the drugmaker relented and will make it available to patients like Mauriello. For so many families, an investigational drug is their last shred of hope. 

Congress is now getting involved to perhaps make laws that would allow people to get these potentially life-saving drugs before they're approved by the Food & Drug Administration (FDA). This might be a law that would force expanded access to some of these drugs. 

Click here to sign up for the daily Wake Up Charlotte newsletter

Credit: Bob Mauriello

The fight for expanded use of investigation drugs is taking another step forward with House Bill 3537, which would direct the secretary of health and human services to support research and allow more access to drugs that may help patients with ALS live longer. 

"And what this bill does, is, it provides funding to make right to try, a reality. Without it, the drugmakers had to pay for it themselves, but a lot of the companies in the ALS space are small companies," said Michelle Lorenz, a volunteer ALS advocate and co-leader of No More Excuses, which is an ALS watchdog group. 

Lorenz said she hopes more legislators everywhere will endorse the bill because lives and living longer are the goals. 

Credit: Bob Mauriello

“But with ALS, but it’s so rapidly lethal, almost no one qualifies for trials, there’s only about 10% of that population that qualifies for trials, and so there are about 28,000 people here in the United States that can't get access to investigational drugs," Lorenz said.

RELATED: 'It is a significant step': FDA approves new Alzheimer's drug

“Very frustrating,” said Mauriello.

There are many faces and lives affected by ALS. Investigational drugs like Tofersen, given at early diagnosis several months ago, would have been helpful to spend more time with Mauriello. 

RELATED: 'This isn't just about Lisa': Supporters take fight to Biogen HQ for access to new drug

“The chances of her being able to benefit from Tofersen in mid-July, if she is still even with us, are remote, because if she is still alive at that time, she will have deteriorated so much, it wouldn’t be much quality of life," Lorenz said.

Biogen will make the drug available to patients in the fall. Meanwhile, Team Lisa is making an impact by crafting a legacy — and maybe a law — so that other families get what Lisa won't: more time.

Some North Carolina legislators have signed onto the bill but Lorenz is hoping more lawmakers from the Carolinas and other states join the fight. Currently, two of North Carolina's 13 representatives have signed. In South Carolina, two of seven representatives are behind the bill. None of the states' combined four senators have endorsed the bill. 

Contact Bill McGinty at bmcginty@wcnc.com and follow him on Facebook.